Laura Julien
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Early Endosome Disturbance and Endolysosomal Pathway Dysfunction in Duchenne Muscular Dystrophy.
Journal: The American journal of pathology
Published: January 10, 2025
Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription.
Journal: Scientific reports
Published: January 19, 2022
Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy.
Journal: Molecular therapy. Nucleic acids
Published: August 11, 2021
Alternative splicing of clathrin heavy chain contributes to the switch from coated pits to plaques.
Journal: The Journal of cell biology
Published: December 11, 2019
A Muscle Hybrid Promoter as a Novel Tool for Gene Therapy.
Journal: Molecular therapy. Methods & clinical development
Published: March 20, 2019
An embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouse.
Journal: Science translational medicine
Published: November 19, 2018
Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
Journal: Journal of neuropathology and experimental neurology
Published: February 07, 2018
Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.
Journal: EMBO molecular medicine
Published: December 17, 2017
RFX1 and RFX3 Transcription Factors Interact with the D Sequence of Adeno-Associated Virus Inverted Terminal Repeat and Regulate AAV Transduction.
Journal: Scientific reports
Published: July 07, 2017
Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles.
Journal: Human molecular genetics
Published: March 30, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026